NELVUTAMIG for Neoplasm malignant: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 6 adverse event reports in the FDA FAERS database where NELVUTAMIG was used for Neoplasm malignant.

Most Reported Side Effects for NELVUTAMIG

Side Effect	Reports	%	Deaths	Hosp.
Off label use	29	10.5%	6	12
Immune-mediated hepatitis	18	6.5%	2	12
Hypothyroidism	17	6.1%	0	6
Immune-mediated enterocolitis	16	5.8%	5	6
Malignant neoplasm progression	16	5.8%	3	6
Colitis	15	5.4%	1	3
Drug ineffective	14	5.1%	3	0
Immune-mediated hepatic disorder	14	5.1%	0	2
Fatigue	13	4.7%	0	3
Immune-mediated myocarditis	11	4.0%	1	8
Diarrhoea	10	3.6%	0	4
Rash	10	3.6%	0	4
Hepatitis	9	3.3%	0	2
Immune-mediated hypophysitis	9	3.3%	0	4
Immune thrombocytopenia	9	3.3%	0	2